Indications and uses
relieves occasional constipation (irregularity) generally produces a bowel movement in 6 to 12 hours
relieves occasional constipation (irregularity) generally produces a bowel movement in 6 to 12 hours
take preferably at bedtime or as directed by a doctor do not exceed maximum dosage age starting dosage maximun dosage adults and children 12 years of age or older 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor
each tablet contains: calcium 4 mg, sodium 8 mg store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)
Drugs Facts
Docusate sodium 50 mg
Sennosides 8.6 mg
Stool softener
Stimulant laxative
relieves occasional constipation (irregularity)
generally produces a bowel movement in 6 to 12 hours
Do not use
this product if you are presently taking mineral oil, unless directed by a doctor
laxative products for longer than 1 week unless directed by a doctor
Ask a doctor before use if you have
stomach pain
nausea
vomiting
noticed a sudden change in bowel habits that continues over a period of 2 weeks
Stop use and ask a doctor ifyou have rectal bleeding or fail to have bowel movement after use of a laxative. These may indicate a serious condition.
If pregnant or breast-feeding,ask a health professional before use.
Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.
take preferably at bedtime or as directed by a doctor
do not exceed maximum dosage
| age | starting dosage | maximun dosage |
| adults and children 12 years of age or older | 2 tablets once a day | 4 tablets twice a day |
| children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
| children 2 to under 6 years | 1/2 tablet once a day | 1 tablet twice a day |
| children under 2 years | ask a doctor | ask a doctor |
each tablet contains: calcium 4 mg, sodium 8 mg
store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)
colloidal silicon dioxide, croscarmellose sodium, D&C Yello #10 Aluminum Lake, FD&C Yellow #6 Aluminum Lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, titanium dioxide
Call 516-341-0666
8:30am-4:30pm ET, Mon-Fri
Repackaged and Relabeled by:
Enovachem PHARMACEUTICALS
Torrance, CA 90501
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76420-918-01 | Sennosides and Docusate Sodium | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 76420-918-30 | Sennosides and Docusate Sodium | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 76420-918-60 | Sennosides and Docusate Sodium | 60 in 1 BOTTLE | TABLET | 60 | 1 | |
| 76420-918-90 | Sennosides and Docusate Sodium | 90 in 1 BOTTLE | TABLET | 90 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76420-918-01 | EA - Each | 76420-918 | 2b1dc849-cd90-429f-bdb0-b2d26b4555fe | 1 | 2025-12-16 |
| 76420-918-30 | EA - Each | 76420-918 | 9c740598-59ec-4309-96e1-014fc75e81b3 | 1 | 2025-12-16 |
| 76420-918-60 | EA - Each | 76420-918 | 4a74e332-f81e-4023-a838-81f0bb1b684a | 1 | 2025-12-16 |
| 76420-918-90 | EA - Each | 76420-918 | c69acccf-1598-4347-a911-b35b781f1256 | 1 | 2025-12-16 |
| 69618-065-01 | EA - Each | 69618-065 | 35e11638-08d0-404a-80a4-fbbd3dd082f2 | 1 | 2021-03-02 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 76420-918 | 76420-918-30, 76420-918-60, 76420-918-90, 76420-918-01 |
| 69618-065 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| D&C YELLOW NO. 10 | 35SW5USQ3G | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| SENNOSIDES | 3FYP5M0IJX | ACTIB |
| DOCUSATE SODIUM | F05Q2T2JA0 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sennosides and Docusate Sodium | SENNOSIDES, DOCUSATE SODIUM | Asclemed USA, Inc. | 2db546de-20dc-4697-aff2-12471f073b1d | 2025-02-08 | Warnings | 76420-918-60 76420-918-30 76420-918-90 76420-918-01 76420-918 76420091890 76420091801 76420091830 76420091860 2d9d8f71-cc36-459a-e063-6394a90acf8e 2db546de-20dc-4697-aff2-12471f073b1d |
| Sennosides and Docusate Sodium | SENNOSIDES, DOCUSATE SODIUM | Reliable-1 Laboratories LLC | a97a1829-f62f-2014-e053-2a95a90a8cc5 | 2025-01-15 | Warnings | 69618-065 |
Adverse event summaries are temporarily unavailable. Other product information remains available.